Installux Stock Quote ALLUX - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Europe
EU
Installux SA (ALLUX) Quote

Installux SA (ALLUX)

286.00

0.00

(0.00%)

Closed May 15 11:30AM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

286.00

Bid

286.00

Ask

316.00

Volume

0.00

0.00 Day's Range 0.00

234.00 52 Week Range 342.00

Market Cap

Previous Close

286.00

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

14

Shares Outstanding

280,099

Dividend Yield

2.80%

PE Ratio

17.82

Earnings Per Share (EPS)

23.46

Revenue

163.48M

Net Profit

6.57M

Sector

Hardware, Nec

Industry

Fabr Metal,ex Machy,trans Eq

Website

www.groupe-installux.com

Headquarters

Villefranche-sur-saone, Rhone, Fra

Founded

1923

Installux SA is listed in the Hardware sector of the Euronext with ticker ALLUX. The last closing price for Installux was 286.00 €. Over the last year, Installux shares have traded in a share price range of 234.00 € to 342.00 €.

Installux currently has 280,099 shares outstanding. The market capitalization of Installux is 117.08 € million. Installux has a price to earnings ratio (PE ratio) of 17.82.

INSTALLUX S.A. : Avis de mise à disposition de l'avis de convocation/réunion à l'AG du 11 juin 2024 et du nombre d'actions et de droits de vote

INSTALLUX S.A. : Avis de mise à disposition de l'avis de convocation/réunion à l'AG du 11 juin 2024 et du nombre d'actions et de droits de vote AVIS DE MISE À DISPOSITION DE...

INSTALLUX : Rapport financier annuel 2023

INSTALLUX : Rapport financier annuel 2023 INSTALLUX : Rapport financier annuel 2023 Pièce jointe Installux - Rapport financier annuel 2023

INSTALLUX S.A. : Communiqué sur les résultats 2023

INSTALLUX S.A. : Communiqué sur les résultats 2023 COMMUNIQUÉ : RÉSULTATS ANNUELS 2023 Saint-Bonnet-de-Mure, le 29 mars 2024 à 20h00 Les comptes annuels du Groupe Installux au 31 décembre...

INSTALLUX S.A. : Rapport financier semestriel 30/06/2023

INSTALLUX S.A. : Rapport financier semestriel 30/06/2023 INSTALLUX S.A. : Rapport financier semestriel 30/06/2023 Pièce jointe Groupe Installux - rapport financier 30-06-2023

Installux - Avis de mise à disposition des documents préparatoires à l'AG du 20 juin 2023

Installux - Avis de mise à disposition des documents préparatoires à l'AG du 20 juin 2023 Avis de mise à disposition des documents préparatoires à l’AG du 20 juin 2023 INSTALLUX S.A...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2	-0.694444444444	288	288	268	4	287.53846154	DE
4	4	1.41843971631	282	290	256	20	284.75	DE
12	-20	-6.53594771242	306	330	256	14	284.61938534	DE
26	30	11.71875	256	330	234	132	275.62653815	DE
52	-54	-15.8823529412	340	342	234	81	277.2293175	DE
156	-86	-23.1182795699	372	494	234	82	349.04886966	DE
260	-14	-4.66666666667	300	494	234	81	348.43236558	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0

gawti88

gawti88 5 minutes ago

LOL i love shorters!!! haha

ACE13

ACE13 5 minutes ago

They just filed for an extension of 5 trading days from the 15th.

Eli's Gone

Eli's Gone 5 minutes ago

Singhania

Singhania 5 minutes ago

$BSEM Reports Huge Jump In Revenue And Gross Margin
Revenue: Increased to $41.9 million in Q1 2024 from $600,000 in Q1 2023.
Gross Margin: Rose to 95% in Q1 2024 from 82% in Q1 2023.
Net Income: Reported positive for the first time on a US GAAP basis.
https://finance.yah

1hot toddy

1hot toddy 5 minutes ago

CEO COMPANY SAYS WORTH BILLIONS THAT WHAT WE WANT. $$$$$$$$$$$$$$$$$$$$$$

CAN11

CAN11 6 minutes ago

absolute failure .0001 for years.

Mark

Mark 6 minutes ago

$GWAV over .07 again in A/Hs

CAN11

CAN11 6 minutes ago

more meaningless news.

Bizreader

Bizreader 6 minutes ago

Yeah super cool.

I'm going through all my paperwork here and I see 2 green ballots and one yellow pack for each of the securities and now I remember that I photocopied them, filled them out, and sent them in. This way I could prove whether or not I actually received them.

BADALI

BADALI 6 minutes ago

How is your chart telling here. If you sold then you lost money here

CAN11

CAN11 6 minutes ago

What success? Complete failure.

Shev11

Shev11 6 minutes ago

If we're all wondering about form C

By submitting a Form C, filers are claiming that they are planning to raise money through a crowdfunding campaign and are exempt from registering their business’s securities with the SEC. Form C filers do not have the same obligations for submitting

Singhania

Singhania 6 minutes ago

$BSEM blows away estimates
$BSEM looks interesting; they blew away estimates, revenue increased to 41.9 million. You heard it here first https://finance.yahoo.com/news/biostem-technologies-inc-bsem-q1-070914107.html

al44

al44 6 minutes ago

Indoctrination vs education =

https://i.imgur.com/z4FfwiG.png

highlandernew

highlandernew 7 minutes ago

🔴🔴Citadel COKEHEADS night shift STARTED on AMC?:

Their great "leader" needs to transfer more offshore... for HIMSELF.

https://investorshub.advfn.com/uimage/uploads/2024/5/15/mhrukAMC_COKEHEADS_AH.png
https

LTListener

LTListener 7 minutes ago

Yeah, I think I read that about the CX- in my DD review. I have not seen anything similar for KRM-II-81, not to say that it wont have any issues in human clinicals, but I think it is similar enough to current treatments only with much less deficiency in performance.

To me the most

dstep

dstep 7 minutes ago

Or simply time passing and getting closer to EOQ and IDE being filed.

tw0122

tw0122 7 minutes ago

ASTS $2.99 + 23%

Nextbigone

Nextbigone 7 minutes ago

$MATH https://www.marketwatch.com/articles/hong-kong-crypto-bitcoin-3be92a76?mod=mw_quote_news

rbl100

rbl100 7 minutes ago

Actually plenty have come back. They died and were revived. Hundreds explained details of people, conversations, actions and places they should not have known while clinically dead. Tons of proof. Pam Reynolds was documented entirely in 1991. 21 grams is the weight of the soul documented scient

Jay_B

Jay_B 7 minutes ago

Chaaaadddd... where's the fu**ing 3-31-24 quarterly report? For the love of all that's holy man. Wake up!!

Nihil8

Nihil8 7 minutes ago

337 days in EM.

Singhania

Singhania 7 minutes ago

I’m watching $BSEM, regenerative medicine is hot, the stock is cheap compared to peer group companies, read their research report here $SINGT $FFIE $SLNA $REBN $TTOO
https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_05152024_BSEM_Sorensen.pdf

shermann7

shermann7 7 minutes ago

Deflation As Economy Comes To A Halt | Michael Pento - Liberty and Finance - VIDEO

https://www.youtube.com/watch?v=PASIvx7hs18

Shermann

123tom

123tom 7 minutes ago

Thank you. Very helpful.

Knightswan Acquisition

RevolutionPopuli ERC20 Token

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions